Patent · US Active

Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

US9932338B2 · kind B2 · utility

0Cited by

1References

17Claims

0Family size

Assignee

Chiesi Farmaceutici S.p.A. · IT

Inventors

Laura Carzaniga · Parma, IT
Fabio Rancati · Parma, IT
Andrea Rizzi · Parma, IT
Ian Linney · London, GB

Key dates

Filing date	Nov 30, 2016
Grant date	Apr 3, 2018
Priority date	—
Expiry date	Nov 30, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I), defined herein, act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.